189 related articles for article (PubMed ID: 22333708)
21. [Epidermoid carcinomas of the anal canal treated with definitive radiation therapy in a series of 305 patients].
Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Houry S; Gallot D; Parc R; Huang R; Qu SH; Pène F; Schlienger M
Cancer Radiother; 2003 Aug; 7(4):237-53. PubMed ID: 12914857
[TBL] [Abstract][Full Text] [Related]
22. Sphincter preservation with chemoradiation in anal canal carcinoma: abdominoperineal resection in selected cases?
Grabenbauer GG; Matzel KE; Schneider IH; Meyer M; Wittekind C; Matsche B; Hohenberger W; Sauer R
Dis Colon Rectum; 1998 Apr; 41(4):441-50. PubMed ID: 9559628
[TBL] [Abstract][Full Text] [Related]
23. [Treatment of advanced anal cancer].
Norum J; Wist E
Nord Med; 1992; 107(8-9):227-8. PubMed ID: 1408730
[TBL] [Abstract][Full Text] [Related]
24. Molecular biomarkers correlate with disease-free survival in patients with anal canal carcinoma treated with chemoradiation.
Ajani JA; Wang X; Izzo JG; Crane CH; Eng C; Skibber JM; Das P; Rashid A
Dig Dis Sci; 2010 Apr; 55(4):1098-105. PubMed ID: 19399614
[TBL] [Abstract][Full Text] [Related]
25. Advanced anal squamous cell carcinoma -- radiotherapy or surgery?
Smigielski J; Rychter A; Fijuth J; Brocki M
Chirurgia (Bucur); 2012; 107(5):626-30. PubMed ID: 23116837
[TBL] [Abstract][Full Text] [Related]
26. Desmocollin 1 and desmoglein 1 expression in human epidermis and keratinizing oral mucosa: a comparative immunohistochemical and molecular study.
Donetti E; Bedoni M; Boschini E; Dellavia C; Barajon I; Gagliano N
Arch Dermatol Res; 2005 Jul; 297(1):31-8. PubMed ID: 15926049
[TBL] [Abstract][Full Text] [Related]
27. Combined modality therapy for HIV-infected patients with squamous cell carcinoma of the anus: outcomes and toxicities.
Edelman S; Johnstone PA
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):206-11. PubMed ID: 16904522
[TBL] [Abstract][Full Text] [Related]
28. Squamous cell carcinoma of the anal canal.
Mitchell SE; Mendenhall WM; Zlotecki RA; Carroll RR
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):1007-13. PubMed ID: 11240241
[TBL] [Abstract][Full Text] [Related]
29. Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes.
Klas JV; Rothenberger DA; Wong WD; Madoff RD
Cancer; 1999 Apr; 85(8):1686-93. PubMed ID: 10223561
[TBL] [Abstract][Full Text] [Related]
30. Conservative management of squamous cell carcinoma of the anal canal.
Basser RL; Smith JG; Worotniuk V; Guiney MJ
Aust N Z J Surg; 1994 Nov; 64(11):754-8. PubMed ID: 7945082
[TBL] [Abstract][Full Text] [Related]
31. [Prognosis of epidermoid anal carcinoma regression after conservative treatment].
Vorob'ëv GI; Odariuk TS; Orlova LP; Nechushkin MI; Rybakov EG
Vopr Onkol; 2004; 50(6):663-7. PubMed ID: 15755059
[TBL] [Abstract][Full Text] [Related]
32. Induction chemotherapy followed by radiotherapy in the treatment of anal cancer.
Lee DH; Kim I; Song HH; Jung JY; Kim DY; Lee KW; Kim TY; Heo DS; Bang YJ; Ha SW; Park JG; Kim NK
Oncol Rep; 2003; 10(1):101-4. PubMed ID: 12469152
[TBL] [Abstract][Full Text] [Related]
33. Polo-like kinase 3 and phosphoT273 caspase-8 are associated with improved local tumor control and survival in patients with anal carcinoma treated with concomitant chemoradiotherapy.
Rödel F; Martin D; Helmke C; Balermpas P; Fokas E; Wieland U; Rave-Fränk M; Kitz J; Matthess Y; Raab M; Strebhardt K; Rödel C
Oncotarget; 2016 Aug; 7(33):53339-53349. PubMed ID: 27462786
[TBL] [Abstract][Full Text] [Related]
34. Prognostic Relevance of HPV Infection and p16 Overexpression in Squamous Cell Anal Cancer.
Mai S; Welzel G; Ottstadt M; Lohr F; Severa S; Prigge ES; Wentzensen N; Trunk MJ; Wenz F; von Knebel-Doeberitz M; Reuschenbach M
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):819-27. PubMed ID: 26530750
[TBL] [Abstract][Full Text] [Related]
35. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial.
Ajani JA; Winter KA; Gunderson LL; Pedersen J; Benson AB; Thomas CR; Mayer RJ; Haddock MG; Rich TA; Willett C
JAMA; 2008 Apr; 299(16):1914-21. PubMed ID: 18430910
[TBL] [Abstract][Full Text] [Related]
36. Treatment of invasive squamous cell carcinoma complicating anal Buschke-Löwenstein tumor: a case history.
Marsh RW; Agaliotis D; Killeen R
Cutis; 1995 Jun; 55(6):358-60. PubMed ID: 7544255
[TBL] [Abstract][Full Text] [Related]
37. The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapy.
Weber DC; Kurtz JM; Allal AS
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):675-80. PubMed ID: 11395235
[TBL] [Abstract][Full Text] [Related]
38. FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy.
Day FL; Link E; Ngan S; Leong T; Moodie K; Lynch C; Michael M; Winton Ed; Hogg A; Hicks RJ; Heriot A
Br J Cancer; 2011 Aug; 105(4):498-504. PubMed ID: 21792197
[TBL] [Abstract][Full Text] [Related]
39. Combined treatment of squamous cell carcinoma of the anal canal: radical radiation therapy with 5-fluorouracil and mitomycin-C, a preliminary report.
Cummings BJ; Harwood AR; Keane TJ; Thomas GM; Rider WD
Dis Colon Rectum; 1980 Sep; 23(6):389-91. PubMed ID: 7418575
[TBL] [Abstract][Full Text] [Related]
40. Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy.
Rödel F; Wieland U; Fraunholz I; Kitz J; Rave-Fränk M; Wolff HA; Weiss C; Wirtz R; Balermpas P; Fokas E; Rödel C
Int J Cancer; 2015 Jan; 136(2):278-88. PubMed ID: 24839133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
